PERSPECTA

News from every angle

← Back to headlines

Soleno Therapeutics (SLNO) Remains Attractive Despite Slower U.S. Launch Projections

Soleno Therapeutics (SLNO) continues to appear attractive to investors, even with slower U.S. launch ramp projections for its products.

1 Apr, 09:35 — 1 Apr, 09:35
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual4d ago

Soleno Therapeutics (SLNO) Still Appears Attractive Despite Slower U.S. Launch Ramp Projections

Read full article →

Related Stories

Philippine Lawmaker Proposes Targeted Energy Crisis Response Bill

just now

Philippine Aviation Authority Explores Sustainable Aviation Fuel Adoption

just now

Philippine President Considers Fuel Excise Tax Suspension

just now

Ferry Fares Rise on Batangas–Occidental Mindoro Route

just now